List Title | APhA DrugInfoLine

Cardiology

SORT BY: Most Recent Most Viewed

October 1, 2000

Blood Pressure in Diabetes: Multiple Drugs Needed to Attain Lower Goals

READ

PREVIEW
For the 11 million Americans who have both diabetes and hypertension, the National Kidney Foundation (NKF) has suggested lowering the goal of blood pressure treatment to 130/80 mm Hg. Intensive...
September 1, 2000

NHLBI: Systolic Hypertension, Elevated Pulse Pressure Need Treatment, Especially in the Elderly

READ

PREVIEW
Systolic blood pressure should become the principal clinical end point for the detection, evaluation, and treatment of hypertension, the National Heart, Lung, and Blood Institute (NHLBI) said in...
July 1, 2000

Tenecteplase: New Thrombolytic Agent Administered in Just 5 Seconds

READ

PREVIEW
Tenecteplase (TNKase—Genentech) is a just-introduced thrombolytic agent that is taking rapid therapy for acute myocardial infarction to new levels. It is marketed with a needleless...
July 1, 2000

The Next NTI Controversy: Antiarrhythmic Agents

READ

PREVIEW
After several years of watching pharmaceutical companies spar over the therapeutic equivalency of warfarin products, pharmacists—especially those involved with formulary systems—will...
May 1, 2000

Congestive Heart Failure: Focus on Pharmacotherapy, Monitoring

READ

PREVIEW
Evidence is now irrefutable that beta-blockers should be used in most patients with congestive heart failure (CHF), and monitoring of the disease with brain natriuretic peptide may soon be...

Pages

Medication Monitor

RSS Follow Medication Monitor on Twitter Follow APhA Druginfoline on Twitter

2215 Constitution Avenue NW, Washington, DC 20037 Telephone 202-628-4410 Fax 202-783-2351

© 2013 American Pharmacists Association All Rights Reserved.

About the American
Pharmacists Association

The American Pharmacists Association (APhA) is the organization whose members are recognized in society as essential in all patient care settings for optimal medication use that improves health, wellness and quality of life. Through information, education and advocacy, APhA empowers its members to improve medication use and advance patient care.

About APhA DrugInfoLine

APhA DrugInfoLine (ISSN 2162-3015) is a weekly publication of, and is owned and copyrighted by the American Pharmacists Association, the national professional society of pharmacists. Materials in APhA DrugInfoLine do not neccessarily represent the policy, recommendations, or endorsement of APhA. The publisher, authors, editors, reviewers, and contributors have taken care to ensure that the information contained in APhA DrugInfoLine is accurate and current; however, they shall have no ability to any person or entity with regard to claims, losses, or damage caused or alleged to be caused, directly or indirectly by use of any information contained in the publication. All decisions about drug therapy must be based on independent judgement of the clinician.